What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to announce and provide investors with updated financial outlooks for fiscal year 2023 and a preliminary outlook for fiscal year 2024, alongside new long-term financial targets and an updated capital allocation framework. It also serves to inform about strategic updates and an ongoing business review.

Where can I find more details about the information disclosed in this 8-K?

More detailed information is available in the press release furnished as Exhibit 99.1 to this 8-K filing. The company also hosted an Investor Day event on June 8, 2023, with a webcast and slide presentation accessible on Cardinal Health's Investor Relations website (ir.cardinalhealth.com).

What does the updated capital allocation framework imply for investors?

The updated capital allocation framework suggests that Cardinal Health is refining its strategy for deploying capital. While specific details are likely elaborated in the press release and Investor Day materials, it generally indicates a plan to balance investments in growth, debt management, and returns to shareholders, reflecting a focus on optimizing shareholder value.

When did the company provide these updates?

The information was announced on June 8, 2023, with the 8-K filing made on the same date. The Investor Day event also took place on June 8, 2023.

CAH 8-K: Regulation FD

Summary

Cardinal Health, Inc. (CAH) filed an 8-K on June 8, 2023, to announce significant updates regarding its financial outlook and strategic direction, as detailed in a press release furnished as an exhibit. The company provided an updated outlook for fiscal year 2023 and a preliminary outlook for fiscal year 2024. Investors should note the introduction of long-term financial targets and an updated capital allocation framework, which signal a renewed focus on shareholder value and disciplined financial management. These announcements were made in conjunction with an Investor Day event where management further elaborated on growth strategies and ongoing business reviews.

Key Highlights

1Updated fiscal year 2023 financial outlook provided.
2Preliminary fiscal year 2024 financial outlook released.
3New long-term financial targets introduced.
4Revised capital allocation framework announced.
5Strategic updates and ongoing business portfolio review discussed.
6Investor Day event held to elaborate on outlook and strategies.
7Press release furnished as an exhibit to the 8-K filing.

CARDINAL HEALTH INC 8-K Report, Regulation FD Disclosure (Jun 8, 2023)

Summary

Key Highlights

Frequently Asked Questions